These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8131127)

  • 21. Ethics and industry-sponsored research.
    Pater JL; Parulekar W; O'Callagham C; Shepherd L; Eisenhouer E; Seymour L; Tu D; Ding K
    CMAJ; 2002 Mar; 166(5):581-2. PubMed ID: 11898934
    [No Abstract]   [Full Text] [Related]  

  • 22. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
    Williams JR
    CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
    [No Abstract]   [Full Text] [Related]  

  • 24. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
    Blehart B
    J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
    [No Abstract]   [Full Text] [Related]  

  • 25. We need dialogue and discussion, not a new Berlin Wall.
    Erola JA
    CMAJ; 1994 Mar; 150(6):955-6. PubMed ID: 8131128
    [No Abstract]   [Full Text] [Related]  

  • 26. Collaborating with pharmaceutical research. Family physicians beware!
    Ogle K
    Can Fam Physician; 2002 Sep; 48():1415-7, 1427-9. PubMed ID: 12371295
    [No Abstract]   [Full Text] [Related]  

  • 27. Physicians, gifts and the pharmaceutical industry.
    Uzych L
    Nebr Med J; 1991 Sep; 76(9):311-2. PubMed ID: 1944698
    [No Abstract]   [Full Text] [Related]  

  • 28. The Medical Council of India guidelines on industry-physician relationship: breaking the conspiracy of silence.
    Nagral J; Roy N
    Natl Med J India; 2010; 23(2):69-71. PubMed ID: 20925200
    [No Abstract]   [Full Text] [Related]  

  • 29. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CMA guidelines on MD-drug industry relations part of international trend.
    Williams JR
    CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
    [No Abstract]   [Full Text] [Related]  

  • 31. CMA issues revised guidelines on physicians' relationship with pharmaceutical industry.
    Williams JR
    CMAJ; 1994 Jan; 150(2):263, 265. PubMed ID: 8287352
    [No Abstract]   [Full Text] [Related]  

  • 32. [Residents and pharmaceutical industry].
    Chabot JM
    Rev Prat; 2004 Apr; 54(8):875-6. PubMed ID: 15274462
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 34. HSFC/CCS pharmaceutical roundtable: a model of contribution of industry to cardiovascular research. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society.
    Dagenais GR
    Can J Cardiol; 1994 Sep; 10(7):699-701. PubMed ID: 7922824
    [No Abstract]   [Full Text] [Related]  

  • 35. Key aspects of physician and pharmaceutical industry relationships for trainees.
    Jain S
    Acad Psychiatry; 2010; 34(2):98-101. PubMed ID: 20224015
    [No Abstract]   [Full Text] [Related]  

  • 36. Student rally. Med school attendees write ethics code on drug firms.
    Romano M
    Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
    [No Abstract]   [Full Text] [Related]  

  • 37. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A survey of the interactions between psychiatry residency programs and the pharmaceutical industry.
    Varley CK; Jibson MD; McCarthy M; Benjamin S
    Acad Psychiatry; 2005; 29(1):40-6. PubMed ID: 15772403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for interaction with the pharmaceutical industry.
    Colby WD
    CMAJ; 1995 Apr; 152(7):1040-2. PubMed ID: 7712409
    [No Abstract]   [Full Text] [Related]  

  • 40. Residents and pharmaceutical representatives.
    Lexchin J
    Can Fam Physician; 1998 Jul; 44():1448. PubMed ID: 9678269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.